公开(公告)号：WO2008136705A3

公开(公告)日：2008-12-31

申请号：PCT/RU2008000164

申请日：2008-03-14

申请人： CHERNOBAYEV NIKOLAY EVGENIEVIC

发明人： CHERNOBAYEV NIKOLAY EVGENIEVICH

IPC分类号： A61K36/61 ,  A61K9/02 ,  A61K31/10 ,  A61K31/125 ,  A61K36/185 ,  A61K36/28 ,  A61P13/08 ,  A61P15/10 ,  A61P35/00

CPC分类号： A61K36/185 ,  A61K9/02 ,  A61K31/10 ,  A61K31/125 ,  A61K36/28 ,  A61K36/61

摘要： The invention relates to the chemical and pharmaceutical industry, in particular to a drug for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and to a method for the use thereof. The inventive drug is based on dextrorotary (D) or levogeratory (L) or racemic (DL) camphor in the form of a fatty-oil-dimexide emulsion (Emulsio Camphorae Axungio Oleo-Dimexidosa), an oil-aqueous emulsion (Emulsio Camphorae Oleo-Aguosa) or in the form of suppositories, the camphor quantity being of 0.1-15.0 % by volume. The above-listed drugs are rectally administrable once a day by course of therapy upto 20 days every year. The camphor preparations increase the resistance of tissue colloids, exhibit antagonistic action with respect to capillary poisons, activate the erection center of the sacral part of the parasympathetic nervous system, exhibit M- and H-cholinolytic action, produce tonic action on the ejaculation center situated in the symphatic part of the central nervous system, normalise the capillary and venule tonus, stimulate vasomotor centers of the spinal chord, enhance the synthesis of macroergic phosphates and inhibit ATPacid splitting in the hypoxia conditions and exhibit analgesic, bactericidal and fibrinolytic effect. The inventive drug and method make it possible to carry out the preventive treatment of the above-listed disease during many decades.

摘要翻译： 本发明涉及化学和制药工业，特别涉及用于治疗和预防良性前列腺增生，前列腺炎，阳ency，不孕症和前列腺癌的药物及其使用方法。 本发明的药物基于脂肪 - 油 - 二甲基乳液（Emulsio Camphorae Axungio Oleo-Dimexidosa）形式的右旋（D）或左旋酸（L）或外消旋（DL）樟脑），油 - 水乳液（Emulsio Camphorae Oleo -Aguosa）或以栓剂的形式，樟脑的量为0.1-15.0％（体积）。 上述药物每天直接给药一次，每次一次，最多20天。 樟脑制剂增加组织胶体的抵抗力，对毛细血管毒素表现出拮抗作用，激活副交感神经系统骶骨部分的勃起中心，展示M-和H-胆固醇分解作用，在射精中心产生紧张作用 在中枢神经系统的交界部分，使毛细血管和小静脉正常化，刺激脊髓的血管舒缩中心，增强大孔磷酸盐的合成，抑制缺氧条件下的ATP酸分解，呈现止痛，杀菌，纤维蛋白溶解作用。 本发明的药物和方法使得可以在几十年内对上述疾病进行预防性治疗。